Cargando…
Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk
BACKGROUND: Concern about costs and antiretroviral therapy (ART)-associated toxicities led to the consideration of CD4 driven strategies for the management of HIV. That approach was evaluated in the SMART trial that reported an unexpected increase of cardiovascular events after treatment interruptio...
Autores principales: | Tebas, Pablo, Henry, William Keith, Matining, Roy, Weng-Cherng, Deborah, Schmitz, John, Valdez, Hernan, Jahed, Nasreen, Myers, Laurie, Powderly, William G., Katzenstein, David |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292263/ https://www.ncbi.nlm.nih.gov/pubmed/18431498 http://dx.doi.org/10.1371/journal.pone.0002021 |
Ejemplares similares
-
Studies on the Relation of the Kidney to Cardiovascular Disease. II
por: Winternitz, M. C., et al.
Publicado: (1940) -
Possible Interruption of Measles Virus Transmission, Uganda, 2006–2009
por: Baliraine, Frederick N., et al.
Publicado: (2011) -
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
por: Wyles, David L, et al.
Publicado: (2018) -
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
por: Wyles, David L, et al.
Publicado: (2021) -
Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS)
por: Wyles, David L, et al.
Publicado: (2023)